NewsGate Press Network

India’s Drug regulator has given nod to Biological E’s Corbevax as a booster for the recipients of Covaxin and Covishield after their primary vaccination with 2 doses, the firm announced on Saturday the 4th of June 2022.

With this, Corbevax has become the first vaccine approved as a heterologous Covid-19 booster.

The Covid-19 vaccine by the Hyderabad based pharmaceutical firm has been allowed as booster for beneficiaries aged 18 and above.

Adults who completed their two does regimen of Covid-19 vaccination by Covaxin or Covishield can take Corbevax as the third dose. So far only homologous doses (same vaccine) has been given as the third jab in the nationwide vaccination programme against Covid-19.